Vanderbilt TB Center News

WHO Global TB Report was released!

Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.

Publication Announcement: “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis"

The U.S. Centers for Disease Control and Prevention (CDC) Tuberculosis Trials Consortium (TBTC), together with collaborators from the National Institutes of Health’s (NIH) AIDS Clinical Trial Group (ACTG), is pleased to announce the publication of “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis" in the New England Journal of Medicine.

Vanderbilt TB Center FY 2020 Annual Report has been released!

The TB Center Annual Report from FY 2020 has now been published, detailing Center activities, research, and funding for the 2020 fiscal year. See the link below to download the full report. We look forward to continued progress toward our research goals in the current year.

Heather Ewing presents MPH Thesis on TB and Stigma

Heather Ewing, MA(c), MPH(c), presented her MPH thesis on Friday, March 2, titled "Knowledge of Tuberculosis is Associated with Greater Expression of Stigma in Brazil". This project stemmed from a Vanderbilt Trans-Institutional Program grant (TIPs), which focused on healthcare in Brazil.